In addition, the other therapeutic agents against HOTAIR such as tumor specific peptides or Dioscin, have been used to inhibit the expression of HOTAIR in ovarian cancer, breast cancer and gastric cancer [50, 51]. This evidence concerns the gene HOTAIR and breast carcinoma.